Abbott price target lowered to $120 from $145 at Benchmark

Benchmark lowered the firm’s price target on Abbott (ABT) to $120 from $145 and keeps a Buy rating on the shares. Abbott reported an in-line quarter and updated guidance to include the recently completed Exact Sciences acquisition, notes the analyst, who calls concerns about organic growth “overblown.”